Genesis Biopharma Inc., of Los Angeles, named Marvin S. Hausman chief scientific officer...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management
Alios BioPharma Inc., of South San Francisco, appointed Carol L. Brosgart chief medical officer...Genesis Biopharma Inc., of Los Angeles, named Anthony J. Cataldo president and CEO
AVI BioPharma Inc., of Bothell, Wash., added Graham Johnson as senior vice president of preclinical development and research, named Patrick Iversen senior vice president of research and innovation and appointed Ryszard Kole senior vice president and AVI distinguished scientist
to chief operating officer and David R. Holland to senior vice president of sales and marketing...Limerick BioPharma Inc., of South San Francisco, named Jill Carroll vice president of strategic corporate development
Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...Ambrilia Biopharma Inc., of Montreal, appointed Faraj Nakhleh to its board
Sutro Biopharma Inc., of South San Francisco, named Daniel H. Petree to its board, named Henry Heinsohn vice president of development and manufacturing, and Lesley Stolz as vice president of business development
Alios BioPharma Inc., of South San Francisco, appointed K. Peter Hirth to its board...Cellular Dynamics International, of Madison, Wis., appointed Leroy Hood and George Church to its scientific advisory board
DOR BioPharma Inc., of Ewing, N.J., appointed Brian L. Hamilton as senior vice president and chief medical officer, and named Gregg Lapointe to the board
AVI BioPharma Inc., of Portland, Ore., appointed Stephen B. Shrewsbury chief medical officer and senior vice president of clinical and regulatory affairs Biota Holdings Ltd., of Melbourne, Australia, appointed James Fox as a nonexecutive director and chairman
ARCA biopharma Inc., of Broomfield, Colo., appointed Kathryn E. Falberg chief financial officer and chief operating officer...DOR BioPharma Inc., of Ewing, N.J., has formed a medical advisory board for its DOR201 (oral beclomethasone dipropionate) product consisting of Chairman George B. McDonald, and members Lisa Kachnic, Marvin Rotman
Genesis Biopharma Inc., of Los Angeles, named Marvin S. Hausman chief scientific officer...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management